The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Vertex Pharmaceuticals Inc., consolidated income statement
US$ in thousands
|Income statement item||Description||The company|
|Revenues||Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.||Vertex Pharmaceuticals Inc.’s revenues increased from 2017 to 2018 and from 2018 to 2019.|
|Income (loss) from operations||The net result for the period of deducting operating expenses from operating revenues.||Vertex Pharmaceuticals Inc.’s income (loss) from operations increased from 2017 to 2018 and from 2018 to 2019.|
|Income (loss) before (provision for) benefit from income taxes||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Vertex Pharmaceuticals Inc.’s income (loss) before (provision for) benefit from income taxes increased from 2017 to 2018 and from 2018 to 2019.|
|Net income (loss) attributable to Vertex||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Vertex Pharmaceuticals Inc.’s net income (loss) attributable to Vertex increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.|